Post-kala-azar dermal leishmaniasis (PKD)L in South-East Asia. A combination of Liposomal amphotericin B (LAmB) (total dose, 20 mg/kg administered IV on days 1, 4, 8, 11 and 15) plus miltefosine (allometric dose orally BID for 21 days) or LAmB monotherapy (total dose, 20 mg/kg administered IV on days 1, 4, 8, 11 and 15) is suggested for the treatment of PKDL.
- Año
- 2026
- Institución
- World Health Organization
Recomendado a favor
Condicional
Certeza de la evidencia
Muy baja